Sanofi (SNY) News Today $56.63 +2.16 (+3.97%) As of 02:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Fisher Asset Management LLC Trims Stake in Sanofi (NASDAQ:SNY)Fisher Asset Management LLC lowered its position in Sanofi (NASDAQ:SNY - Free Report) by 6.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,511,027 shares of the company's stock after selling 848,083 shaMarch 2 at 6:19 AM | marketbeat.comNewEdge Wealth LLC Has $1.58 Million Stock Position in Sanofi (NASDAQ:SNY)NewEdge Wealth LLC boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 20.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,799 shares of the company's stock after buying an additional 5,591 shares during thMarch 2 at 4:07 AM | marketbeat.comAltrius Capital Management Inc Buys 7,865 Shares of Sanofi (NASDAQ:SNY)Altrius Capital Management Inc lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 5.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 161,940 shares of the company's stock after acquiring an additional 7,8March 1 at 6:52 AM | marketbeat.comSanofi (NASDAQ:SNY) Stock Position Trimmed by QRG Capital Management Inc.QRG Capital Management Inc. cut its position in Sanofi (NASDAQ:SNY - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 143,510 shares of the company's stock after selling 8,896 shares duringMarch 1 at 4:54 AM | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by Bank of New York Mellon CorpBank of New York Mellon Corp decreased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 70.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,785,316 shares of the company's stock after selling 6,527,260 shaMarch 1 at 3:59 AM | marketbeat.comNVAX Earnings: Novavax Stock Jumps Despite Mixed Q4 ResultsFebruary 27, 2025 | markets.businessinsider.comRegeneron: Is It the Perfect Biotech Stock for Value and Growth? (SNY)Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.February 27, 2025 | marketbeat.comEquity Investment Corp Sells 52,395 Shares of Sanofi (NASDAQ:SNY)Equity Investment Corp reduced its stake in Sanofi (NASDAQ:SNY - Free Report) by 2.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,406,189 shares of the company's stock after selling 52,395 shares during the quarter. SanofiFebruary 27, 2025 | marketbeat.comU.S. to spend up to $1B for bird flu responseFebruary 26, 2025 | msn.comHealth Rounds: Experimental Sanofi drug delays heart valve disease progression, and potentially surgeryFebruary 26, 2025 | reuters.comEnveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150MFebruary 26, 2025 | businesswire.comFulcrum Therapeutics reports Q4 EPS (31c), consensus (29c)February 26, 2025 | markets.businessinsider.comPress Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myelomaFebruary 25, 2025 | globenewswire.comSanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel DiseaseFebruary 24, 2025 | benzinga.comZacks Research Forecasts Sanofi's Q2 Earnings (NASDAQ:SNY)Sanofi (NASDAQ:SNY - Free Report) - Equities researchers at Zacks Research reduced their Q2 2025 earnings per share (EPS) estimates for shares of Sanofi in a research note issued on Wednesday, February 19th. Zacks Research analyst K. Shah now forecasts that the company will post earnings per sharFebruary 24, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Stock Position Lowered by 44 Wealth Management LLC44 Wealth Management LLC lessened its holdings in Sanofi (NASDAQ:SNY - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 66,830 shares of the company's stock after selling 5,031 shares durinFebruary 23, 2025 | marketbeat.comAtlantic Family Wealth LLC Invests $262,000 in Sanofi (NASDAQ:SNY)Atlantic Family Wealth LLC bought a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,431 shares of the company's stock, valued at approximately $262,000. Several other hedgFebruary 23, 2025 | marketbeat.comOxbow Advisors LLC Purchases 4,790 Shares of Sanofi (NASDAQ:SNY)Oxbow Advisors LLC lifted its position in Sanofi (NASDAQ:SNY - Free Report) by 4.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 104,749 shares of the company's stock after purchasing an additional 4,790 shares during thFebruary 23, 2025 | marketbeat.comZacks Research Has Bearish Estimate for Sanofi Q1 EarningsFebruary 23, 2025 | americanbankingnews.comSanofi (SNY): Among the Cheap Pharmaceutical Stocks to Buy According to AnalystsFebruary 23, 2025 | insidermonkey.comWhat is Zacks Research's Forecast for Sanofi Q1 Earnings?Sanofi (NASDAQ:SNY - Free Report) - Zacks Research reduced their Q1 2026 earnings estimates for shares of Sanofi in a research note issued on Wednesday, February 19th. Zacks Research analyst K. Shah now anticipates that the company will earn $1.05 per share for the quarter, down from their priorFebruary 22, 2025 | marketbeat.comSanofi Consumer Healthcare India Releases Audited Financials for 2024February 22, 2025 | tipranks.comWaterfront Wealth Inc. Boosts Stock Holdings in Sanofi (NASDAQ:SNY)Waterfront Wealth Inc. grew its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 46.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,958 shares of the company's stock after acquiring an additional 15,748February 22, 2025 | marketbeat.comPress Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's diseaseFebruary 22, 2025 | globenewswire.comFirst meeting of CDC vaccine advisory panel under RFK Jr. postponedFebruary 20, 2025 | msn.comSanofi Consumer Healthcare India Announces Major Stake Acquisition DealFebruary 20, 2025 | tipranks.comSanofi’s Dupixent Achieves FDA Priority Review for Bullous Pemphigoid TreatmentFebruary 20, 2025 | tipranks.comStrategic Financial Concepts LLC Acquires New Stake in Sanofi (NASDAQ:SNY)Strategic Financial Concepts LLC acquired a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 13,821 shares of the company's stock, valued at approximately $667,000February 20, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Increases Stock Holdings in Sanofi (NASDAQ:SNY)Allspring Global Investments Holdings LLC boosted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 128.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,330 shares of the company's stocFebruary 20, 2025 | marketbeat.comNew Bill: Senator Kevin Cramer introduces S. 106: Chiropractic Medicare Coverage Modernization Act of 2025February 19, 2025 | quiverquant.comSanofi: Sanofi and CD&R sign Opella share purchase agreementFebruary 19, 2025 | finanznachrichten.deSanofi: OpenAI's Research Agents Could Lead To Explosive GrowthFebruary 19, 2025 | seekingalpha.comSanofi to sell 50% stake in consumer health unit to CD&RFebruary 19, 2025 | seekingalpha.comTruist Financial Corp Sells 36,611 Shares of Sanofi (NASDAQ:SNY)Truist Financial Corp lessened its stake in Sanofi (NASDAQ:SNY - Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 560,623 shares of the company's stock after selling 36,611 shares during the period. TruisFebruary 19, 2025 | marketbeat.comPrincipal Securities Inc. Sells 8,920 Shares of Sanofi (NASDAQ:SNY)Principal Securities Inc. decreased its stake in Sanofi (NASDAQ:SNY - Free Report) by 19.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,130 shares of the company's stock after selling 8,920 shares during the perFebruary 19, 2025 | marketbeat.comPress Release: Sanofi and CD&R sign Opella share purchase agreementFebruary 19, 2025 | globenewswire.comRegeneron, Sanofi announce Dupixent sBLA accepted for priority review by FDAFebruary 18, 2025 | markets.businessinsider.comFDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For DiabetesFebruary 18, 2025 | benzinga.comValeo Financial Advisors LLC Sells 8,976 Shares of Sanofi (NASDAQ:SNY)Valeo Financial Advisors LLC decreased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 62.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,496 shares of the company's stock after selling 8,976 shares during the quarter. Valeo FinanciaFebruary 18, 2025 | marketbeat.comRegeneron and Sanofi Announce FDA Priority Review for Dupixent® as Potential First Targeted Treatment for Bullous PemphigoidFebruary 18, 2025 | quiverquant.comLegacy Capital Wealth Partners LLC Has $586,000 Stake in Sanofi (NASDAQ:SNY)Legacy Capital Wealth Partners LLC trimmed its holdings in Sanofi (NASDAQ:SNY - Free Report) by 49.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,157 shares of the company's stock after selling 1February 17, 2025 | marketbeat.comBlue Trust Inc. Lowers Stock Holdings in Sanofi (NASDAQ:SNY)Blue Trust Inc. reduced its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 33.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,098 shares of the company's stock after selling 5,948 shares durinFebruary 17, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by Van ECK Associates CorpVan ECK Associates Corp boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 18.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 662,762 shares of the company's stock after purchasing an additional 10February 15, 2025 | marketbeat.comSanofi price target raised to EUR 110 from EUR 105 at JPMorganFebruary 14, 2025 | markets.businessinsider.comFDA approves Sanofi biosimilar product for treatment of diabetesFebruary 14, 2025 | markets.businessinsider.comSanofi gets FDA approval for NovoLog insulin biosimilarFebruary 14, 2025 | msn.comAMUNDI's Strategic Acquisition of Sanofi SA Shares: A Detailed AnalysisFebruary 14, 2025 | gurufocus.comKestra Private Wealth Services LLC Has $946,000 Holdings in Sanofi (NASDAQ:SNY)Kestra Private Wealth Services LLC lowered its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 23.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,604 shares of the company's stock after sellinFebruary 14, 2025 | marketbeat.comSanofi: Filing of the 2024 U.S. Form 20-F and French "Document d'Enregistrement Universel" containing the Annual Financial ReportFebruary 13, 2025 | finanznachrichten.deAlnylam: Waiting For Regulatory Updates In MarchFebruary 13, 2025 | seekingalpha.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.740.71▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼1713▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News NVS News GSK News TAK News ARGX News BNTX News TEVA News GMAB News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNY Stock Alerts